UBS Group
YDESW

UBS Group’s YD Bio Ltd Warrants YDESW Stock Holding History

UBS Group’s Portfolio YDESW Stock Details YDESW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-372
Closed -$368 – 11698
2025
Q4 		$368 Buy
+372
New +$525 ﹤0.01% 10001

Other funds holding YDESW

CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
TNA
True North Advisors Dallas, Texas $877M AUM 13.86% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $9.2B AUM 23.26% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return

UBS Group's YDESW Position: Q1 2026 in Review

UBS Group sold out of YD Bio Ltd Warrants (YDESW) in Q1 2026, closing a stake of 372 shares — an estimated $368 sold.

UBS Group first reported a position in YDESW in Q4 2025 and held it in 1 quarter. The position peaked at $368 in Q4 2025. 9 funds tracked by Wall St. Rank hold YDESW as of Q1 2026.

  • UBS Group reported no remaining YD Bio Ltd Warrants position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 372 YD Bio Ltd Warrants shares in Q1 2026, an estimated $368.
  • UBS Group first reported a position in YD Bio Ltd Warrants in Q4 2025 and held it in 1 quarter.
  • UBS Group's YD Bio Ltd Warrants position peaked at $368 in Q4 2025.
  • 9 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.